Chuck Triano | Senior Vice President of Investor Relations |
Albert Bourla | Chief Executive Officer |
Frank D’Amelio | Chief Financial Officer |
Mikael Dolsten | President of Worldwide Research and Development |
Angela Hwang | Group President, Pfizer Biopharmaceuticals Group |
Chris Schott | JP Morgan |
Umer Raffat | Evercore |
David Risinger | Morgan Stanley |
Tim Anderson | Wolfe Research |
Steve Scala | Cowen |
Navin Jacob | UBS |
Andrew Baum | Citi |
Terence Flynn | Goldman Sachs |
Louise Chen | Cantor Fitzgerald |
Geoff Meacham | Bank of America |
Good day, everyone, and welcome to Pfizer’s Third Quarter 2019 Earnings Conference Call. Today’s call is being recorded.
At this time, I would like to turn the call over to Mr. Chuck Triano, Senior Vice President of Investor Relations. Please go ahead, sir.